Lidocaine Recall: Eugia US HCl Injection 2% 40 mg/2 mL
FDA recalls Lot 3LC26029A (exp Feb 2029) and Lot 3LC26031A (exp Mar 2029) of Lidocaine HCl Injection, USP 2%, 40 mg/2 mL, Rx Only, manufactured in India for Eugia US. The recall is due to a labeling issue where the barcode wrap covers the barcode making it hard to scan. The product was distributed nationwide in the US and about 168,300 vials may be affected.
| Brand | Eugia US LLC |
|---|---|
| Product | Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 |
| Reason | Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan |
| Severity | low |
| Units affected | 168300 |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check the lot numbers on your product and do not use any that match the recalled lots.
- Return or arrange disposal of the affected vials through the supplier or healthcare provider; request a replacement if available.
- Contact your pharmacist or healthcare professional with questions and monitor recall updates from the FDA.
How to identify the recalled item
| Lot / date codes | Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029 |
|---|---|
| Lot / date codes | Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other lidocaine recalls
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.